DAPSONE (dapsone) by Viatris (2) is clinical pharmacology actions: the mechanism of action in dermatitis herpetiformis has not been established. Approved for sulfone [epc]. First approved in 1979.
Drug data last refreshed 19h ago
CLINICAL PHARMACOLOGY Actions: The mechanism of action in Dermatitis herpetiformis has not been established. By the kinetic method in mice, Dapsone is bactericidal as well as bacteriostatic against Mycobacterium leprae . Absorption and Excretion: Dapsone, when given orally, is rapidly and almost…
Sulfone
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Safety and Efficacy Trial of ACZONE (Dapsone) Gel, 7.5% in 9 to 11 Year-Old Patients With Acne Vulgaris
Photoallergy Potential of Dapsone Gel in Healthy Volunteers
Phototoxicity Test of Dapsone Gel in Healthy Volunteers
Dermal Tolerability of Dapsone Gel in Healthy Volunteers
A Study of Dapsone Gel in Females With Skin of Color and Acne Vulgaris
Worked on DAPSONE at Viatris (2)? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.